# The Branded Health Service Medicines (Costs) Regulations 2018, Paragraph 3


The manufacturer or supplier referred to in paragraph 1(b) is a manufacturer or supplier that would be required to make payments under regulation 3 or under a direction given under regulation 4 for a period of one or more of their complete accounting reference periods were it not for the fact that regulation 3(6) or 4(5) applied.
Table 1
Column (1)Length of current accounting reference period
Column (2)Likely net sales income
Twelve months
£6 million
Less than twelve months
£6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period
More than twelve months
£6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period
Table 2
Column (1)Length of previous accounting reference period
Column (2)Net sales income
Twelve months
£6 million
Less than twelve months
£6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period
More than twelve months
£6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period

---
Source: https://www.legislation.gov.uk/uksi/2018/345/schedule/2/paragraph/3 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-regulations-2018/schedule-2/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.